UPCOMING SESSIONS in ET
Wed, Apr 8, 2026
10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next Heather Landau Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all sessions

External Beam Radiation Therapy for Amyloidosis of the Urinary Bladder

Key Information
Source
Practical Radiation Oncology
Year
2017
summary/abstract
Amyloidosis is a condition characterized by the extracellular deposition of amyloid, a fibrillary substance consisting of low-molecular-weight protein subunits. Amyloidosis may present either as a systemic disorder or as a process isolated to a specific organ without systemic involvement.
Localized amyloidosis can occur in any tissue within the body. Primary bladder amyloidosis (PBA) is a rare disorder that presents with gross, painless hematuria that may be accompanied by lower urinary tract symptoms (LUTS). The computed tomography (CT) and cystoscopic findings of PBA can easily be confused with malignancy. The pathologic diagnosis of amyloidosis depends on affinity to Congo Red dye and apple-green birefringence under polarizing light microscopy.
Abstract Source
https://www.ncbi.nlm.nih.gov/pubmed/28958583
Full Text Source
https://www.practicalradonc.org/article/S1879-8500(17)30245-X/fulltext
DOI
10.1016/j.prro.2017.08.003
Authors
Cooper CT, Greene BD, Fegan JE, Rovira D, Gertz MA, Marcus DM
Organisation
University of Newcastle, Australia; Valley View Hospital, US; Mayo Clinic, US